top of page

Publications

  1. Oya Incekara, Tolga Acun; “DNAJC9 expression in basal-like and luminal A breast cancer subtypes predicts worse survival”, Molecular Biology Reports (2023) https://doi.org/10.1007/s11033-023-08654-4  (SCI-E, Q3, IF: 2.7)

  2. Elif Beyza Kartaloglu, Melih Oztepe, Oguzhan Akgun, Tolga Acun, Ferda Ari and Elif Uz Yildirim “Identification of ALX3 Gene Promoter Hypermethylation as a Potential Biomarker for Lung Cancer” Anticancer Research, 43(7):3029-3036 (2023) https://doi.org/10.21873/anticanres.16474 (SCI-E, Q4, IF: 2.4)

  3. Tolga Acun, Oya Incekara; “High DNAJA4 expression correlates with poor survival outcomes in breast cancer”, Revista Romana de Medicina de Laborator, 30(4):369-378 (2022) https://doi.org/10.2478/rrlm-2022-0035 (SCI-E, Q4, IF: 0.5)

  4. Furkan Celebi ILERI, Tolga ACUN; “High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer”, Biomarkers in Medicine, 15(12):941-50 (2021) https://doi.org/10.2217/bmm-2020-0728 (SCI-E, Q3, IF:2.7)

  5. Tolga Acun “DNAJC25 as a tumor suppressor candidate gene in breast cancer”, Hacettepe J. Biol. & Chem., 49(3):305-311(2021) https://doi.org/10.15671/hjbc.725263 (Biological Abstracts, BIOSIS Previews, Zoological Record)

  6. Tolga Acun, Kerem Mert Senses; “Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer”, Breast Cancer, 27(3):483-489 (2020)  https://doi.org/10.1007/s12282-019-01042-6 (SCI-E, Q2, IF:3.4)

  7. Tolga Acun, Natalie Doberstein, Jens K. Habermann, Timo Gemoll, Christoph Thorns, Emin Oztas, Thomas Ried; “HLJ1 (DNAJB4) gene is a novel biomarker candidate in breast cancer”, OMICS: A Journal of Integrative Biology, 21(5):257-265 (2017). https://dx.doi.org/10.1089%2Fomi.2017.0016 (SCI-E, Q2, IF:3.1)

  8. Muammer Merve AYDIN, Nermin Sumru BAYIN, Tolga ACUN, Mustafa Cengiz YAKICIER, Kamil Can AKÇALI; “Role of FLT3 in the proliferation and aggresiveness of hepatocellular carcinoma”, Turk J Med Sci, 46: 572-581 (2016). https://doi.org/10.3906/sag-1501-173 (SCI-E, Q3, IF:1.0)

  9. Tolga Acun, Kubilay Demir, Emin Oztas, Diego Arango, M. Cengiz Yakicier; “PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas”, OMICS: A Journal of Integrative Biology, 19(4): 220-229 (2015). https://doi.org/10.1089/omi.2015.0010 (SCI-E, Q2, IF:3.1)

  10. Yasemin Soysal*, Tolga Acun#, CM Lourenço, W Jr Marques, M Cengiz Yakıcıer; “Muscle Hemangiomatosis Presenting As A Severe Feature In A Patient With The Pten Mutation: Expanding The Phenotype Of Vascular Malformations In Bannayan-Riley-Ruvalcaba Syndrome”, Balkan J Med Genet., 15/1, 45-50, (2012). # Equal contribution. https://doi.org/10.2478/v10034-012-0007-x (SCI-E, Q4, IF:0.8)

  11. Tolga Acun, Emin Oztas, Tamer Yagci, M Cengiz Yakicier; “SIP1 is Downregulated in Hepatocellular Carcinoma by Promoter Hypermethylation”, BMC Cancer, 11:223, (2011). https://doi.org/10.1186/1471-2407-11-223 (SCI-E, Q2, IF:4.3)

  12. Tolga Acun, Ece Terzioğlu-Kara, Ozlen Konu, Mehmet Ozturk, M Cengiz Yakicier; “Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma”, Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis, 684: 106–108, (2010). https://doi.org/10.1016/j.mrfmmm.2009.11.008 (SCI-E, Q1, IF:2.4)

  13. Fatih İzgü, Demet Altınbay, Tolga Acun; “Killer toxin of Pichia anomala NCYC 432; purification, characterization and its exo-β-1,3-glucanase activity”, Enzyme and Microbial Technology, 39(4): 669-676, (2006). https://doi.org/10.1016/j.enzmictec.2005.11.024 (SCI-E, Q3, IF:3.6)

 

Proceedings 

​​

  1. Oya Candan, Shams Sarimammadli, Sena Sönmez, Tolga Acun* (2025) “Expression, survival and functional analysis of DNAJC9-AS1 lncRNA in breast cancer” 3rd International Thales Congress on Life, Engineering, Architecture and Mathematics, April 24-25, 2025 Cairo, Egypt.  (*Oral Presentation)​

  2. Shams Sarımammadlı*, Tolga Acun (2024) "Expression, Alternative Polyadenylation Process and Epigenetic Regulation of MRPS16 gene in Breast Cancer" International Conference on Multidisciplinary Sciences and Technological Developments (ICMUSTED 2024), December 13-15, 2024, Erzurum/Türkiye. (*Oral Presentation)

  3. Sena Sönmez*, Tolga Acun (2024) “CLPB is overexpressed in breast cancer and its expression correlated with unfavorable survival values” 7th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2024) October 02-04, 2024. (*Oral Presentation)​

  4. Elif Beyza Kartaloğlu*, Melih Öztepe, Oğuzhan Akgün, Tolga Acun, Ferda Arı, Elif Uz Yıldırım (2021)“Hypermethylation of ALX3 gene promoter is a novel biomarker candidate in lung cancer” 4th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2021) November 24-26, 2021. (*Oral Presentation)

  5. Oya İncekara*, Tolga Acun (2020) “High expression of DNAJC9 correlates with unfavorable survival out come in breast cancer” International Eurasian Conference on Biotechnology and Biochemistry (BioTechBioChem 2020) December 16-18, 2020, Ankara, Turkey (*Oral Presentation)

  6. T. Acun*; (2020) "DNAJC16 expression is associated with favorable prognostic values in breast cancer" 3rd International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2020) March 19-20, 2020, Ankara, Turkey (*Oral Presentation)

  7. F.Ç. İleri*, T. Acun; (2019) “Analysis of DNAJA1 (HDJ2) gene as a biomarker candidate in breast cancer”; 1st International Congress on Medical Sciences and Biotechnology, 14-16, Oct., 2019, Uşak, Turkey (*Oral Presentation)

  8. T. Acun, K.M. Şenses; (2019) “DNAJC10 (ERDJ5) is a novel biomarker candidate in breast cancer” International Participated Erciyes Medical Genetics Days, 21-23, Feb, 2019, Kayseri, Turkey. (Oral Presentation) doi: 10.14744/etd.2019.55631.

  9. T. Acun, E. Oztas, T. Ried; (2015) “HLJ1 (DNAJB4) is epigenetically downregulated in breast cancer”; IV. International Congress of the Molecular Biology Association of Turkey, 27-29 November 2015, Ankara, Turkey. 

  10. T. Acun, K. Demir, E. Oztas, M.C. Yakicier; (2012) “Genetic and Epigenetic Alterations of PTPRD in Hepatocellular Carcinoma”; European Journal of Cancer, vol. 48, suppl. 5 (2012), ISSN 0959-8049, S25–S288, S123. [22nd Biennial Congress of the European Association for Cancer Research, 7–10 July 2012, Barcelona, Spain]

  11. Y. Soysal, T. Acun, C. M. Lourenço, W. Marques Jr, C. Yakıcıer; (2012) “Muscle hemangiomatosis as a severe presenting feature in a patient with PTEN mutation: Expanding the phenotype of vascular malformations in Bannayan-Riley-Ruvalcaba syndrome”; European Journal of Human Genetics, Volume 20, Supplement 1, June 2012, page 58, P02.038 [European Human Genetics Conference 2012, June 23 - 26, 2012, Nürnberg, Germany]

  12. CB Akyerli, D Agirbasli, T Acun, O Sahin, MC Yakicier; (2010) “Analysis of genetic variations caused by environmental factor aflatoxin in hepatocellular carcinoma”; Clinical Genetics 2010; 78 (Suppl. 1): 57–77 (page:74) [ Clinical Genetics Special Issue: Abstracts of the 9th National Medical Genetics Congress, 1-5 December 2010, Istanbul, Turkey ]

  13. D Agirbasli, CB Akyerli, T Acun, A Keller, MC Yakicier; (2010) “Lincrna Expression in Hepatocellular Carcinoma”; Clinical Genetics 2010; 78 (Suppl. 1): 57–77 (page:74) [ Clinical Genetics Special Issue: Abstracts of the 9th National Medical Genetics Congress, 1-5 December 2010, Istanbul, Turkey ]

  14. M. Yakicier, T. Acun, S. Dizlek, A. Timuragaoglu; (2009) “A branched dna-based technique for detection of BCR-ABL gene products”; Haematologica-The Hematology Journal ; 94[suppl.2]:17 abs. 0041, 2009 (14th Annual Meeting of the European-Hematology-Association, Jun 2009, Berlin, Germany)

  15. T. Acun, E. Terzioğlu, O. Konu, M. Ozturk and M.C. Yakicier; (2007) “MDM2 SNP309 G allele and TP53 mutations are mutually exclusive in human hepatocellular carcinomas”; ILCA Annual Conference, Book of Abs., p.21, Oct. 2007, Barcelona / Spain

  16. T. Acun and M.C. Yakicier; (2006) "Genetic analysis of hepatocellular carcinoma candidate tumor supressor genes and oncogenes"; FEBS Journal Volume 273, Issues1, Page 368-371, Jun 2006 (31st FEBS Congress,"Molecules in Health and Disease", June 2006, Istanbul / Turkey)

  17. F.İzgü, D. Altınbay, T. Acun; (2003) “Isolation and characterization of K4 type yeast killer protein”; Society for General Microbiology, 153rd Meeting, 2003, UMIST, Manchester.

©2019 by Tolga Acun

bottom of page